D. Croom-carter

发表

Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals

G. Cooper, M. Rowe, A. Rickinson, 1996, Journal of virology.

Epidemiology of Infection with Epstein-Barr Virus Types 1 and 2: Lessons from the Study of a T-Cell-Immunocompromised Hemophilic Cohort

A. Rickinson, F. Hill, C. Conlon, 1998, Journal of Virology.

Novel Intertypic Recombinants of Epstein-Barr Virus in the Chinese Population

S. Leung, A. Chan, A. Rickinson, 2000, Journal of Virology.

Coordinated repression of BIM and PUMA by Epstein–Barr virus latent genes maintains the survival of Burkitt lymphoma cells

A. Strasser, M. Rowe, R. Tierney, 2017, Cell Death and Differentiation.

Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes

A. Rickinson, A. Davies, D. Croom-carter, 1992, Journal of virology.

The effects of acute malaria on Epstein-Barr virus (EBV) load and EBV-specific T cell immunity in Gambian children.

H. Whittle, A. Rickinson, R. Njie, 2009, The Journal of infectious diseases.

Antigen presenting phenotype of Hodgkin Reed-Sternberg cells: analysis of the HLA class I processing pathway and the effects of interleukin-10 on epstein-barr virus-specific cytotoxic T-cell recognition.

P. Murray, A. Rickinson, N. Blake, 1998, Blood.

lymphoproliferative disease patients cells: IgM+IgD+ CD27+ B cells harbour the virus in X-linked Epstein-Barr virus persistence in the absence of conventional memory B

S. Tangye, A. Rickinson, Cindy S. Ma, 2013 .

Epstein-Barr virus persistence in the absence of conventional memory B cells: IgM+IgD+CD27+ B cells harbor the virus in X-linked lymphoproliferative disease patients.

S. Tangye, A. Rickinson, Cindy S. Ma, 2008, Blood.

The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.

M. Rowe, D. Huen, S. Henderson, 1995, Oncogene.

Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers

M. Rowe, D. Huen, A. Rickinson, 1994, Journal of virology.

EBNA 1 Lessons from the EBV Nuclear Antigen T Cell Response : + Priming the Human CD 8 The Importance of Exogenous Antigen in Croom-Carter and

A. Rickinson, D. Croom-carter, T. Haigh, 2000 .

Cytotoxic T-Lymphocyte Responses to a Polymorphic Epstein-Barr Virus Epitope Identify Healthy Carriers with Coresident Viral Strains

A. Rickinson, A. Leese, R. Tierney, 2000, Journal of Virology.

Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individuals

G. Cooper, M. Rowe, A. Rickinson, 1996, Journal of virology.

Different Patterns of Epstein-Barr Virus Latency in Endemic Burkitt Lymphoma (BL) Lead to Distinct Variants within the BL-Associated Gene Expression Signature

Rainer Spang, Paul Kellam, Andrew I. Bell, 2012, Journal of Virology.

Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases

P. Borrow, P. Moss, A. Rickinson, 2017, Journal of Virology.

Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage.

L. Young, M. Rowe, A. Rickinson, 1992, Virology.

Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays.

E. Hui, A. Chan, A. Rickinson, 2006, The Journal of general virology.

Multiple Epstein-Barr virus strains in patients with infectious mononucleosis: comparison of ex vivo samples with in vitro isolates by use of heteroduplex tracking assays.

N. Raab-Traub, A. Rickinson, Sushmita Roy, 2006, The Journal of infectious diseases.

ThreePathways ofEpstein-Barr Virus GeneActivation from EBNAl-Positive Latency inB Lymphocytes

A. Davies, D. Croom-carter, M. Rowe, 1992 .

Epstein-Barr Virus and the Somatic Hypermutation of Immunoglobulin Genes in Burkitt's Lymphoma Cells

M. Neuberger, R. Harris, A. Rickinson, 2001, Journal of Virology.

Epstein-Barr virus persistence in the absence of conventional memory B cells: IgM (cid:1) IgD (cid:1) CD27 (cid:1) B cells harbor the virus in X-linked lymphoproliferative disease patients

S. Tangye, A. Rickinson, Cindy S. Ma, 2008 .

Epstein-Barr virus latent gene sequences as geographical markers of viral origin: unique EBNA3 gene signatures identify Japanese viruses as distinct members of the Asian virus family.

K. Kawa, A. Rickinson, R. Tierney, 2011, The Journal of general virology.

Revisiting the Effect of Acute P. falciparum Malaria on Epstein-Barr Virus: Host Balance in the Setting of Reduced Malaria Endemicity

S. Rowland-Jones, H. Whittle, A. Rickinson, 2012, PloS one.

Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death

E. Kieff, R. Longnecker, M. Rowe, 1991, Cell.

EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins

A. Strasser, P. Colman, M. Rowe, 2019, Cell Death & Differentiation.

Epstein-Barr Virus Nuclear Antigen 2 (EBNA2) Gene Deletion Is Consistently Linked with EBNA3A, -3B, and -3C Expression in Burkitt's Lymphoma Cells and with Increased Resistance to Apoptosis

W. Hammerschmidt, A. Rickinson, R. Tierney, 2005, Journal of Virology.

B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells.

P. Moss, B. Wollenberg, N. Khan, 2002, Blood.

Identification of a TAP-Independent, Immunoproteasome-Dependent CD8+ T-Cell Epitope in Epstein-Barr Virus Latent Membrane Protein 2

V. Cerundolo, A. Rickinson, A. Leese, 2003, Journal of Virology.

antigen efficiently reactivate specific cytotoxic T cells Epstein-Barr virus encoding a foreign - B cells immortalized by a mini

P. Moss, B. Wollenberg, N. Khan, 2013 .

HLA-A11-Restricted Epitope Polymorphism among Epstein-Barr Virus Strains in the Highly HLA-A11-Positive Chinese Population: Incidence and Immunogenicity of Variant Epitope Sequences

A. Chan, A. Rickinson, P. Johnson, 2003, Journal of Virology.

of Variant Epitope Sequences Population : Incidence and Immunogenicity Highly HLA-A 11-Positive Chinese among Epstein-Barr Virus Strains in the HLA-A 11-Restricted Epitope Polymorphism

A. Chan, A. Rickinson, P. Johnson, 2003 .

The Importance of Exogenous Antigen in Priming the Human CD8+ T Cell Response: Lessons from the EBV Nuclear Antigen EBNA11

A. Rickinson, D. Croom-carter, T. Haigh, 2000, The Journal of Immunology.

Epstein-Barr Virus Infection of Naïve B Cells In Vitro Frequently Selects Clones with Mutated Immunoglobulin Genotypes: Implications for Virus Biology

A. Rickinson, R. Feederle, D. Kube, 2012, PLoS pathogens.

EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins

A. Strasser, P. Colman, M. Rowe, 2019, Cell Death & Differentiation.

Epstein-Barr virus persistence in the absence of conventional memory B cells: IgM+IgD+CD27+ B cells harbor the virus in X-linked lymphoproliferative disease patients.

S. Tangye, A. Rickinson, Cindy S. Ma, 2008, Blood.